clinical trial · NCT06363864
Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan
Leeuwenhoek Laboratories Co. Ltd.·—·not yet recruiting·n = 1,200
Metabolic Syndrome
brief summary
The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.
started
Apr 14, 2024
primary completion
Oct 31, 2029
completion
Oct 31, 2029
last updated
Apr 12, 2024
official title
Investigation of Metabolite Differences Between Taiwanese Metabolic Syndrome and Healthy Group Through Metabolomics
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol